Next Article in Journal
In Situ Profiling of the Three Dominant Phyla Within the Human Gut Using TaqMan PCR for Pre-Hospital Diagnosis of Gut Dysbiosis
Previous Article in Journal
Antifungal Activity of Anionic Defense Peptides: Insight into the Action of Galleria mellonella Anionic Peptide 2
Previous Article in Special Issue
The SNP rs2298383 Reduces ADORA2A Gene Transcription and Positively Associates with Cytokine Production by Peripheral Blood Mononuclear Cells in Patients with Multiple Chemical Sensitivity
Open AccessReview

Electrohypersensitivity as a Newly Identified and Characterized Neurologic Pathological Disorder: How to Diagnose, Treat, and Prevent It

1
Association for Research Against Cancer (ARTAC), 57/59 rue de la Convention, 75015 Paris, France
2
European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium
3
Department of Cancer Clinical Research, Paris V University Hospital, 75005 Paris, France
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(6), 1915; https://doi.org/10.3390/ijms21061915
Received: 5 February 2020 / Revised: 3 March 2020 / Accepted: 5 March 2020 / Published: 11 March 2020
Since 2009, we built up a database which presently includes more than 2000 electrohypersensitivity (EHS) and/or multiple chemical sensitivity (MCS) self-reported cases. This database shows that EHS is associated in 30% of the cases with MCS, and that MCS precedes the occurrence of EHS in 37% of these EHS/MCS-associated cases. EHS and MCS can be characterized clinically by a similar symptomatic picture, and biologically by low-grade inflammation and an autoimmune response involving autoantibodies against O-myelin. Moreover, 80% of the patients with EHS present with one, two, or three detectable oxidative stress biomarkers in their peripheral blood, meaning that overall these patients present with a true objective somatic disorder. Moreover, by using ultrasonic cerebral tomosphygmography and transcranial Doppler ultrasonography, we showed that cases have a defect in the middle cerebral artery hemodynamics, and we localized a tissue pulsometric index deficiency in the capsulo-thalamic area of the temporal lobes, suggesting the involvement of the limbic system and the thalamus. Altogether, these data strongly suggest that EHS is a neurologic pathological disorder which can be diagnosed, treated, and prevented. Because EHS is becoming a new insidious worldwide plague involving millions of people, we ask the World Health Organization (WHO) to include EHS as a neurologic disorder in the international classification of diseases. View Full-Text
Keywords: electrohypersensibility; multiple chemical sensitivity; neurologic disease; oxidative stress; melatonin; O-myelin; inflammation; histamine; radiofrequency; extremely low frequency; electromagnetic fields electrohypersensibility; multiple chemical sensitivity; neurologic disease; oxidative stress; melatonin; O-myelin; inflammation; histamine; radiofrequency; extremely low frequency; electromagnetic fields
Show Figures

Figure 1

MDPI and ACS Style

Belpomme, D.; Irigaray, P. Electrohypersensitivity as a Newly Identified and Characterized Neurologic Pathological Disorder: How to Diagnose, Treat, and Prevent It. Int. J. Mol. Sci. 2020, 21, 1915.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop